By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1 DNA Way

South San Francisco  California  94080-4990  U.S.A.
Phone: 650-225-1000 Fax: 650-225-6000

Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. Upon receiving U.S. Food and Drug Administration licensure in 2007, the Oceanside facility added 90,000 liters of capacity that are now approved for the production of Rituxan and Avastin bulk drug substance.

On the Southern California Coast, halfway between Los Angeles and San Diego, Oceanside is a beautiful beachfront community of roughly 200,000 people. As one of Oceanside’s largest employers, Genentech takes great pride in the impact we have on the community, but also in the impact the community has on our employees.

Please view our company video on YouTube:

Connect with us via Social Media:




Key Statistics

Ownership: Subsidiary

Web Site: Genentech
Employees: 10,000+
Symbol: RHHBY



Company News
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/20/2014 6:12:16 AM
FDA Grants Priority Review For Genentech (RHHBY)’s Lucentis In Diabetic Retinopathy 10/8/2014 10:55:45 AM
Genentech (RHHBY) Sales Reps Banned At Ascension Health 10/3/2014 6:26:43 AM
Genentech (RHHBY)’s Investigational Combination Of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone 9/29/2014 11:56:51 AM
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates 9/29/2014 6:22:40 AM
Google Inc.'s Calico To Hire As Many As 150 Staffers; Some May Be Current Genentech (RHHBY) Employees 9/5/2014 7:02:48 AM
Gilead Sciences, Inc. (GILD), "The New Genentech (RHHBY)," Remaps Massive Foster City Campus 8/29/2014 6:44:11 AM
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014 7:36:34 AM
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014 7:22:41 AM
Genentech (RHHBY) Submits Supplemental Biologics License Application To FDA For Lucentis Indication In Diabetic Retinopathy 8/8/2014 10:34:47 AM